Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 794
Guide Official Revision Description Reason for Update
Version Date Number Of Change
Accommodating Devices to
direct readers to updated
guidance found in Eyes -
Lens Implant Status
Summary.
2025 8/27/2025 19. Administrative In Item 31-34. Eyes, Exam
Techniques 10. Refractive
Procedures. Revised to
match new Disposition
Table.
2025 08/27/2025 20. Medical Policy In Disease Protocols,
Protocol for Coronary Heart
st nd
Disease – 1 and 2 Class,
clarified item #6. Post-Event
Heart Catheterization with
Imaging is not required for
Limited Second Class or
ATCS.
2025 08/27/2025 21. Medical Policy In General Information, AME
Equipment and Medical
Confidentiality revised to
include computerized color
vision testers and
requirement for EKG/ECG
equipment. (A full 12-lead
recorded at 25mm/sec at
10mV is required. Anything
less will not be accepted.)
2025 08/27/2025 22. Medical Policy In the chart of Acceptable
Combinations of Diabetes
Medications, added
bexagliflozin (Brenzavvy) to
SGLT2 Inhibitors.
2025 08/27/2025 23. Medical Policy In the chart of Acceptable
Combinations of Diabetes
Medications, adding to
established treatment, all
Group E is 30 days.
2025 08/27/2025 24. Medical Policy Biologics, Biosimilars, and
Non-biologics page, added
mirikizumab (Omvoh).
2025 08/27/2025 25. Medical Policy In Pharmaceuticals,
Cholesterol Medications
revised PCSK9 Inhibitors
from conditional to
Shown as extracted from the FAA PDF, without paraphrasing. Tables and forms may lose their layout. Underlined references open the Guide location they name.
